Skip to main content
Multiple Sclerosis Discovery Forum
Inspiring Connections
Utility Navigation
Feedback
Newsletter
RSS
Twitter
User Top Menu
Welcome, guest
Log In
Join
Why Join?
Search form
Search
About Us
Overview
Who We Are
Contact
Fan Mail
How to Cite
News & Future Directions
New Findings
News Briefs
Podcasts
News Synthesis
Essays & Opinions
Blogs
Papers
Editors' Picks
Classic Papers
Archive
Forums
Discussions
Webinars
Professional Resources
Meetings & Events
Past Meetings
Funding Opportunities
Jobs
Member Directory
Bulletin Board
Useful Links
Research Resources
Data Visualizations
Clinical Trials - Public Availability of Results
World Map
MS trials baseline
NMO History
NMO Galaxy
Map of MS Prevalence
Progressive MS Authors Galaxy
Word Cloud
MSLine
Ongoing Clinical Trials in MS
MRI-Related Clinical Trials
RRMS and CIS
Immunopathogenesis of MS
The MS Galaxy
ARR in Placebo Groups
Symptoms Prevalence
Scientific Literature TreeMap
Clinical Trials in MS
Drug-Development Pipeline
Tissue Repositories
MSGene
Animal Models
Clinical Trials
Click Here to Support MSDF
You are here
Home
Most Viewed
Peroxisome proliferator activated receptor-γ agonists protect oligodendrocyte progenitors against tumor necrosis factor-alpha-induced damage: Effects on mitochondrial functions and differentiation.
Clustering of autoimmune diseases in patients with rosacea.
Repair strategies for multiple sclerosis: challenges, achievements and perspectives.
Widespread Pressure Pain Hypersensitivity in Patients with Multiple Sclerosis with and Without Pain as Sign of Central Sensitization.
No evidence for an association of osteopontin plasma levels with disease activity in multiple sclerosis.
Multiple sclerosis: evaluation of purine nucleotide metabolism in central nervous system in association with serum levels of selected fat-soluble antioxidants.
microRNAs: A connection between cholesterol metabolism and neurodegeneration.
Oligodendrogenesis in the normal and pathological central nervous system.
Longitudinal 7-year follow-up of chronic pain in persons with multiple sclerosis in the community.
An ex-vivo multiple sclerosis model of inflammatory demyelination using hyperbranched polymer.
NADH-dehydrogenase Type-2 Suppresses Irreversible Visual Loss and Neurodegeneration in the EAE Animal Model of MS.
What is the Real Fate of Vitamin D in Multiple Sclerosis?
Principal components of functional connectivity: A new approach to study dynamic brain connectivity during rest.
Sex-specific extent and severity of white matter damage in multiple sclerosis: Implications for cognitive decline.
8-Hydroxyquinolines: a review of their metal chelating properties and medicinal applications.
Inhibitory effect of matrine on blood-brain barrier disruption for the treatment of experimental autoimmune encephalomyelitis.
Pío del Río Hortega and the discovery of the oligodendrocytes.
Modulation of TLR3/TLR4 inflammatory signaling by the GABAB receptor agonist baclofen in glia and immune cells: relevance to therapeutic effects in multiple sclerosis.
Cutting Edge: Nanogel-Based Delivery of an Inhibitor of CaMK4 to CD4+ T Cells Suppresses Experimental Autoimmune Encephalomyelitis and Lupus-like Disease in Mice.
Biochemical Pharmacology of the Sigma-1 Receptor.
St. John's wort and its component hyperforin alleviate experimental autoimmune encephalomyelitis through expansion of regulatory T-cells.
Effects of pooled human immunoglobulins in an animal model of neuromyelitis optica with chronic application of autoantibodies to aquaporin 4.
Reduction in serum aquaporin-4 antibody titers during development of a tumor-like brain lesion in a patient with neuromyelitis optica: a serum antibody-consuming effect?
OCT: New perspectives in neuro-ophthalmology.
The Relationship Between Balance Confidence and Cognitive Motor Interference in Individuals With Multiple Sclerosis.
Pages
« first
‹ previous
…
560
561
562
563
564
565
566
567
568
…
next ›
last »